ARCHIVES

Therapeutic Modalities Improve Patient Quality of Life In Trials

This article is from The Cancer Letter archive.

Vol. 27 No. 2 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

October 18, 2002

Wyngaarden says NCI’s Special Authorities Are All Right With Him

May 14, 1982

A Biostatistics Paper Alleges Potential Harm To Patients In Two Duke Clinical Studies

October 2, 2009

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

December 30, 2011

Has The Pendulum Swing too Far Toward Grants? NCI, NCAB Ponder Best Way to Stimulate Work In New areas

December 5, 1980

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

July 11, 2014